Prevention and treatment for hepatitis C

Models of good practice for community-based testing, linkage to care and adherence to treatment for hepatitis B and C, HIV, and tuberculosis and for health promotion interventions to prevent infections among people who inject drugs

• 5 December 2022

A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs

• 22 November 2022

Summary of Expert Panel meeting discussions on interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs

• 22 November 2022

Prevention of hepatitis B and C in the EU/EEA and the UK

• 24 November 2020

Toolkit to support the generation of robust estimates of hepatitis C prevalence

• 5 March 2020

Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA

• 5 December 2018

Public health guidance on HIV, hepatitis B and C testing in the EU/EEA

• 23 November 2018

Public health guidance on prevention and control of blood-borne viruses in prison settings

• 23 July 2018

Guidance in brief: Prevention and control of blood-borne viruses in prison settings

• 23 July 2018

Public health guidance on active case finding of communicable diseases in prison settings

• 23 May 2018

Systematic review on active case finding of communicable diseases in prison settings

• 23 November 2017

Systematic review on hepatitis B and C prevalence in the EU/EEA

• 10 November 2016

Public health guidance on HIV and STI prevention among men who have sex with men

• 17 June 2015

HIV and hepatitis B and C in Latvia

• 17 April 2015

Risk assessment on change of testing requirements for partner donation of reproductive cells

• 12 June 2012

Country mission Romania: HIV, sexually transmitted infections, and hepatitis B and C

• 16 May 2012

Country mission Estonia: HIV, sexually transmitted infections, and hepatitis B and C

• 15 May 2012